Chittappen Kandiyil Prajeeth (Chittappen K Prajeeth)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

High Fat Diet Induced

Top Venues

Emerging microbes & infections

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Chittappen Kandiyil Prajeeth, Isabel Zdora, Giulietta Saletti, Julia Friese, Thomas Gerlach, Lucas Wilken, Jana Beicht, Mareike Kubinski, Christina Puff, Wolfgang Baumgärtner, Jeroen Kortekaas, Paul J Wichgers Schreur, Albert D M E Osterhaus, Guus F Rimmelzwaan
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging microbes & infections 13 (1) (2024)
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Amare Aregay, Albert D M E Osterhaus, Alina Tscherne, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection. Vaccines 12 (1) (2024)
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Amare Aregay, Albert D M E Osterhaus, Alina Tscherne, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection. Vaccines 12 (1) (2024)
Chittappen Kandiyil Prajeeth, Isabel Zdora, Giulietta Saletti, Julia Friese, Thomas Gerlach, Lucas Wilken, Jana Beicht, Mareike Kubinski, Christina Puff, Wolfgang Baumgärtner, Jeroen Kortekaas, Paul J Wichgers Schreur, Albert D M E Osterhaus, Guus F Rimmelzwaan
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging microbes & infections 13 (1) (2024)
Chittappen Kandiyil Prajeeth, Isabel Zdora, Giulietta Saletti, Julia Friese, Thomas Gerlach, Lucas Wilken, Jana Beicht, Mareike Kubinski, Christina Puff, Wolfgang Baumgärtner, Jeroen Kortekaas, Paul J Wichgers Schreur, Albert D M E Osterhaus, Guus F Rimmelzwaan
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging microbes & infections 13 (1) (2024)
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Amare Aregay, Albert D M E Osterhaus, Alina Tscherne, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection. Vaccines 12 (1) (2024)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Niranjana Nair, Albert D M E Osterhaus, Guus F Rimmelzwaan, Chittappen Kandiyil Prajeeth
Rift Valley Fever Virus-Infection, Pathogenesis and Host Immune Responses. Pathogens (Basel, Switzerland) 12 (9) (2023)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lukas Mathias Michaely, Lukas Schuwerk, Lisa Allnoch, Kathleen Schön, Inken Waltl, Pia-Katharina Larsen, Andreas Pavlou, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan, Stefanie C Becker, Ulrich Kalinke, Wolfgang Baumgärtner, Ingo Gerhauser
Intact Type I Interferon Receptor Signaling Prevents Hepatocellular Necrosis but Not Encephalitis in a Dose-Dependent Manner in Rift Valley Fever Virus Infected Mice. International journal of molecular sciences 23 (20) (2022)
Monique Petry, Martin Palus, Eva Leitzen, Johanna Gracia Mitterreiter, Bei Huang, Andrea Kröger, Georges G M G M Verjans, Wolfgang Baumgärtner, Guus F Rimmelzwaan, Daniel Ruzek, Albert Osterhaus, Chittappen Kandiyil Prajeeth
Immunity to TBEV Related Flaviviruses with Reduced Pathogenicity Protects Mice from Disease but Not from TBEV Entry into the CNS. Vaccines 9 (3) (2021)